Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001177082 | SCV001341215 | likely benign | Cardiomyopathy | 2019-04-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001375551 | SCV001572420 | uncertain significance | not specified | 2021-04-09 | criteria provided, single submitter | clinical testing | Variant summary: MYH7 c.3854-5C>T alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.2e-05 in 251484 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.3854-5C>T has been reported in the literature in one pediatric cardiomyopathy patient with diastolic dysfunction (Quan_2019). The report does not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Invitae | RCV001483851 | SCV001688258 | likely benign | Hypertrophic cardiomyopathy | 2024-01-21 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001177082 | SCV004239463 | uncertain significance | Cardiomyopathy | 2022-07-06 | criteria provided, single submitter | clinical testing |